"The best way to predict the future is to create it."

2011 marks the 24th straight year that Merit Medical Systems, Inc. has expanded its product offering with a pipeline full of new products and line extensions to existing products. This year we launched the ASAP® aspiration catheter in the United States (formerly only available in Europe), TRAM™ and TRAM-P™ manifold with integral transducer, the One-Step™ TAPS (Thoracentesis and Paracentesis Set), the Embosphere® microspheres with syringes made of cyclo olefin polymer (cop), and the Merit Mini Access Kits Non-Vascular (MAK-NV™) with chiba needle. The company’s product development pipeline for 2012 is filled with more than a dozen new opportunities that will help define the future of the company. Peter Drucker, who is recognized globally as the father of modern management, once said “The best way to predict the future is to create it.” We look forward to 2012 and beyond; the future looks positive with many more new products in the development pipeline.

Larry Tolman
Merit Medical Systems, Inc.

Double Digit Growth in U.S. Peripheral Vascular Device Market Through 2018

Merit Medical Systems, Inc. is a strong participant in the transcatheter embolization market with a broad offering of calibrated, hydrophilic spheres including: Embosphere® Microspheres, EmboGold® Microspheres, QuadraSphere® Microspheres, and HepaSphere™ Microspheres. Embosphere Microspheres are indicated for embolization of symptomatic uterine fibroids, hypervascular tumors and arteriovenous malformations. The company is also sponsoring a clinical trial (HiQuality) titled “HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer.”

According to a new report by iData Research, the U.S. peripheral vascular device market in 2011 is valued at over $3.8 billion. The market is expected to grow rapidly to over $7.1 billion by 2018 fueled by sales of many new products and the increased use of transcatheter embolization devices for new indications such as cancer and stroke treatment. “Transcatheter embolization devices, which are used to occlude blood flow within the vasculature, are expected to be the fastest-growing segment in the overall peripheral vascular market,” says Dr. Kamran Zamanian, CEO of iData. “Their uses are going beyond the treatment of aneurysms and other arteriovenous malformations and are being used in the treatment of growths, cancers, and stroke. In particular, sales of particle embolics, which can deliver drug-coated and radiolabeled beads for targeted drug delivery and radiation therapy, are estimated to grow at double-digit rates through 2018.” (Source: http://www.prweb.com/releases/2011/11/prweb8997564.html)

Merit Medical Systems, Inc. is ideally situated to capture some of the market growth resulting from the expansion of transcather embolization procedures.

Larry Tolman
Merit Medical Systems, Inc.

MRG Forecasts Dramatic International Sales Growth

Merit continues to expand sales efforts globally with new sales offices in mainland China, Hong Kong and other strategic areas outside the United States. “In 2010, our international sales grew approximately 10% over our 2009 international sales, and accounted for approximately 32% of our total sales.”1 This expansion is timely and the growth is significant. In a recent business wire dated October 4, 2011, the Millennium Research Group (MRG), a global authority on medical technology market intelligence, stated: “… the Brazilian, Russian, Indian and Chinese interventional cardiology device markets are all expected to grow strongly in the next five years, driven largely by rapid economic growth, which increases both the prevalence of coronary artery disease and the funding available for its treatment.”2

Merit has approximately 175 independent dealer organizations and packers that distribute our products worldwide, including territories in Russia, Africa, the Middle East, Asia (including China and India), South and Central America (including Brazil), Europe (some direct sales representation and some independent dealers), Australia and Canada. We believe that our international sales will continue to increase because of our extensive sales coverage in these areas and because of the dramatic industry growth.

1 2010 Merit Medical Systems, Inc. Annual Report
2 http://www.businesswire.com/news/home/20111004005233/en/Brazilian-Russian-Indian-Chinese-Interventional-Cardiology-Markets

Larry Tolman
Merit Medical Systems, Inc.

Dreamforce Conference and Salesforce.com

We’ve successfully completed the rollout of and training for a new Customer Relationship Management (CRM) program called Salesforce.com with our US Direct and European Direct sales organizations. Salesforce.com is the largest and most successful cloud-based CRM program in the world with more than 77,000 businesses currently using the product. The overall goals of this initiative are to find, attract and win new customers, as well as to nurture and retain the customers the company already has. We look forward to a positive impact on our business by the way we interact with customers using this new initiative.

In preparation for the CRM launch, a group of Merit employees from Marketing, IT and Sales recently attended the 2011 Dreamforce Conference in San Francisco to learn (and share the experience with more than 43,000 other attendees) about the new capabilities. The Dreamforce Conference featured outstanding keynote speakers, interactive demos, in-depth discussions, technical training and more. Merit already has great people with the knowledge and desire to be successful; Salesforce.com gives us one more powerful tool to better position the company for success!

Larry Tolman
Merit Medical Systems, Inc.

MAK-NV™ introducer system with Chiba needles

As the product manager for Merit Medical’s MAK-NV™ introducer system, I am excited to announce the addition of echo-enhanced Chiba needles to this line of products.

The echo-enhanced needle design and radiopaque marker tip on the introducer provide enhanced visibility for quick and efficient access. For a smooth insertion, the dilator and introducer tip design decreases buckling and introducer peelback during insertion.

Richard Collard
Sr. Product Manager

Radial Approach–It’s Time for Options

Transradial access for percutaneous coronary interventions is a growing trend that is helping to shape Merit’s radial approach product line. “Transradial PCI has grown from 1.3% of PCI in the US in 2007 to 4.5% in 2009 and may now be over 10%,” reports Dr. Jennifer Tremmel (Stanford University, CA) who believes “this rate may soon surpass the 29% seen outside the US.”

Merit is perfectly positioned to maximize the radial access opportunity by offering several new product options in a comprehensive radial approach product line, including the Finale® radial compression device and the Prelude® sheath introducer. These products complement Merit’s broad offering of ancillary products used in interventional cardiology and provide additional product selection options for clinicians who prefer the radial approach.

As percutaneous transradial access procedures become more popular among interventionalists all over the world, the need for adequate training in the technique will become increasingly important. In response to this need, Merit is also in the process of implementing radial access training programs. Due to our expanded radial product offering and the radial access training programs, Merit is already experiencing rapid sales growth.

Larry Tolman
Merit Medical Systems, Inc.

Merit Medical Supports Local Initiative to Help Those with Multiple Sclerosis

Merit employees have joined together to support “Accept the Challenge” Utah Bike MS 2011 a local event to help raise money for programs and services that help people with MS. It is gratifying to be a part of this great project and to feel like we are making a difference for this worthy cause.

Larry Tolman
Merit Medical Systems, Inc.

Innovation breeds success

It’s been exciting to see all the new products recently launched here at Merit. At the recent Q1 2011 earnings conference call, CEO Fred Lampropoulos mentioned just a few of the “latest and greatest”. For more than 20 years, the name Merit Medical Systems, Inc. has been synonymous with innovative medical devices used in cardiology and radiology. From the first coronary control syringe launched in 1989 to the ASAP™ clot aspiration catheter that was recently launched in the USA, there has been a consistent flow of new products every year since the founding of the company. As a result of this continual innovation, sales revenues have responded by growing year after year without a single decline from a prior year. I’m even more excited about the new products in our product development pipeline . . . the best is yet to come!

Larry Tolman
VP of Business Analytics

A great loss – Bill Cook

Bill Cook, the founder of Cook Medical, is recognized by many as a pioneer for some of the core products commonly used in cardiology and radiology. His passing will be a great loss to his family, the company and to the entire medical device industry. I’d like to extend my condolences to the family and friends of Bill Cook and the employees of Cook Medical. He will not be forgotten. Antoine de Saint-Exupery captured my thoughts when he said, “He who has gone, so we but cherish his memory, abides with us, more potent, nay, more present than the living man.”

Larry Tolman
VP of Business Analytics

Merit Medical wants to connect with you

At Merit Medical, we’re always looking for new and better ways to serve you, our valued customers and partners. We want to share the many reasons we’re proud of our innovative medical devices for use in cardiology, radiology and endoscopy procedures, so you can make informed purchasing decisions with confidence. We also want your feedback, so we can improve our business and products to meet your needs.

To those ends, Merit Medical is pleased to announce the debut of our blog. In coming posts, you’ll get insights into our business, including the acquisition of BioSphere Medical®. You’ll learn about our products, such as Impress® hydrophilic catheters, EN Snare®, Prelude® short sheaths, Finale™ compression devices, and Miser® contrast managment systems. We’ll also share perspective on the medical device industry, its trends and trade shows, so you can add our knowledge and experience to your own.

You’re invited to connect with us. Subscribe to our blog feed by email or in your favorite reader, so posts come to you automatically. Visit our YouTube channel to watch videos and animations about our products. Browse our Scribd library of product brochures and instructions for use. Join us on Facebook, Twitter and LinkedIn. We look forward to connecting with you.

Thank you for your business.

Tim Walker
VP of Marketing